313
Views
11
CrossRef citations to date
0
Altmetric
Articles

Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort

, , , , , , , , , , , , , , , , , , , & show all
Pages 425-431 | Accepted 24 Nov 2016, Published online: 03 Apr 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (10)

Lauri Weman, Henri Salo, Laura Kuusalo, Johanna Huhtakangas, Johanna Kärki, Paula Vähäsalo, Maria Backström & Tuulikki Sokka-Isler. (2023) Similar levels of disease activity and remission rates in patients with psoriatic arthritis and rheumatoid arthritis—results from the Finnish quality register. Clinical Rheumatology 43:2, pages 633-643.
Crossref
Armaan M Nazir, Bhavya Koganti, Kunal Gupta, Marrium S Memon, Muhammad Bin Aslam Zahid, Vignarth Shantha Kumar, Mamatha Tappiti & Jihan A Mostafa. (2021) Evaluating the Use of Hydroxychloroquine in Treating Patients With Rheumatoid Arthritis. Cureus.
Crossref
Paula Muilu, Vappu Rantalaiho, Hannu Kautiainen, Lauri J. Virta, Johan G. Eriksson & Kari Puolakka. (2020) First-year drug therapy of new-onset rheumatoid and undifferentiated arthritis: a nationwide register-based study. BMC Rheumatology 4:1.
Crossref
Mark Yates, Alexander J MacGregor, Jo Ledingham, Sam Norton, Katie Bechman, Elaine M Dennison & James B Galloway. (2020) Variation and implications of treatment decisions in early rheumatoid arthritis: results from a nationwide cohort study. Rheumatology 59:8, pages 2035-2042.
Crossref
Laura Kuusalo, Tuulikki Sokka‐Isler, Hannu Kautiainen, Päivi Ekman, Markku J. Kauppi, Laura Pirilä, Tuomas Rannio, Toini Uutela, Timo Yli‐Kerttula & Kari Puolakka. (2020) Automated Text Message–Enhanced Monitoring Versus Routine Monitoring in Early Rheumatoid Arthritis: A Randomized Trial. Arthritis Care & Research 72:3, pages 319-325.
Crossref
Rocio V Gamboa-Cárdenas, Manuel F. Ugarte-Gil, Massardo Loreto, Mónica P. Sacnun, Verónica Saurit, Mario H. Cardiel, Enrique R. Soriano, Cecilia Pisoni, Claudio M. Galarza-Maldonado, Carlos Rios, Sebastião C. Radominski, Geraldo da R. Castelar-Pinheiro, Washington Alves Bianchi, Simone Appenzeller, Inés Guimarães da Silveira, Cristiano A. de Freitas Zerbini, Carlo V. Caballero-Uribe, Adriana Rojas-Villarraga, Marlene Guibert-Toledano, Francisco Ballesteros, Rubén Montufar, Janitzia Vázquez-Mellado, Jorge Esquivel-Valerio, Ignacio García De La Torre, Leonor A. Barile-Fabris, Fedra Irazoque Palezuelos, Lilia Andrade-Ortega, Pablo Monge, Raquel Teijeiro, Ángel F. Achurra-Castillo, María H. Esteva Spinetti, Graciela S. Alarcón & Bernardo A. Pons-Estel. (2019) Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort. Clinical Rheumatology 38:10, pages 2737-2746.
Crossref
M. M. A. Verhoeven, P. M. J. Welsing, J. W. J. Bijlsma, J. M. van Laar, F. P. J. G. Lafeber, J. Tekstra & J. W. G. Jacobs. (2019) Effectiveness of Remission Induction Strategies for Early Rheumatoid Arthritis: a Systematic Literature Review. Current Rheumatology Reports 21:6.
Crossref
Hiroyuki Tominaga, Anna MacDowallClaes Olerud. (2019) Surgical treatment of the severely damaged atlantoaxial joint with C1–C2 facet spacers. Medicine 98:22, pages e15827.
Crossref
Laura Kuusalo, Kari Puolakka, Hannu Kautiainen, Anna Karjalainen, Timo Malmi, Leena Paimela, Marjatta Leirisalo-Repo & Vappu Rantalaiho. (2017) High burden of adverse events is associated with reduced remission rates in early rheumatoid arthritis. Clinical Rheumatology 37:6, pages 1689-1694.
Crossref
Serena Bugatti, Garifallia Sakellariou, Terenzj Luvaro, Maria Immacolata Greco & Antonio Manzo. (2018) Clinical, Imaging, and Pathological Suppression of Synovitis in Rheumatoid Arthritis: Is the Disease Curable?. Frontiers in Medicine 5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.